PZ0340

PF-06737007

≥98% (HPLC)

• Synonym(e): 2-((3R,4S)-3-Fluoro-1-(2-(4-(trifluoromethoxy)phenyl)acetyl)piperidin-4-yloxy)-4-(2-hydroxy-2-methylpropoxy)benzamide, 2-[[(3R,4S)-3-Fluoro-1-[2-[4-(trifluoromethoxy)phenyl]acetyl]piperidin-4-yl]oxy]-4-(2-hydroxy-2-methylpropoxy)benzamide, PF06737007
• Empirische Formel (Hill-System): C₂₅H₂₈F₄N₂O₆
• CAS-Nummer: 1863905-38-7
• Molekulargewicht: 528.49
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 329823849
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: white to beige
• Löslichkeit: DMSO: 25 mg/mL, clear
• Lagertemp.: room temp
• SMILES String: F[C@@H]1CN(C(CC2=CC=C(OC(F)(F)F)C=C2)=O)CC[C@@H]1OC3=C(C(N)=O)C=CC(OCC(C)(C)O)=C3

Beschreibung

Biochem./physiol. Wirkung

PF-06737007 is pan tropomyosin-related kinase (Trk) inhibitor.

Sonstige Hinweise

This compound was developed by Pfizer for Kinase Phosphatase Biology research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.

Rechtliche Hinweise

Sold for research purposes under agreement from Pfizer Inc.

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H315,H319,H335
• P-Sätze: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• Gefahreneinstufungen: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Zielorgane: Respiratory system
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable